A collaborative research team has identified a novel blood-based biomarker capable of detecting early-stage lung cancer and ...

British patients are participating in a significant new blood test trial for Alzheimer's that could transform the diagnosis of the lethal disease. Individuals with suspected dementia are being ...

A new blood test for Alzheimer’s disease can accurately detect people with early symptoms, according to research which experts hope to build on and bring us closer to a cure. Scientists from the Mayo ...

Researchers found Alzheimer's biomarkers accurately predicted faster cognitive decline and dementia risk in adults aged 80 and older, supporting more precise diagnosis and care planning.

UK researchers on Wednesday announced the trial of a blood test for Alzheimer's which it is hoped will transform diagnosis of the disease. Researchers at University College London (UCL) will assess ...

Cognitive decline in very old adults has been considered for decades to be an almost inevitable consequence of aging.

A major UCL-led clinical trial, aiming to transform the diagnosis of Alzheimer's disease through a simple blood test, is now welcoming its first participants who will be recruited via memory clinics ...

Right now, the way people are diagnosed with dementia in the UK is not good enough. Current figures estimate that more than a third of people over 65 who are living with dementia in England are ...

OTTAWA, Ontario — Looking for Alzheimer’s disease (AD) biomarkers in plasma instead of cerebrospinal fluid (CSF) is a simpler form of screening individuals for AD pathology and could result in earlier ...